Guoguo Tang

Dr. Guoguo Tang

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
GTGuoguo Tang
Guoguo Tang
MCmiaomiao chi
miaomiao chi
YZYang Zhai
Yang Zhai
RPRongmei Peng
Rongmei Peng
JHJing Hong
Jing Hong
Corneal transplantation is often considered the last resort for severe corneal epithelial disorders, especially limbal stem cell deficiency (LSCD). Tissue engineering offers novel strategies to mitigate the shortage of corneal transplant donors. However, low cell viability and compromised functionality in tissue engineering represent a major challenge. In this review, we describe the key characteristics required for corneal epithelium bioscaffolds. We summarize the research progress centered on optimizing cell activity and functionality in the past 10 years from four key perspectives: the sourcing of cells, seed cell pretreatments, biomaterial optimization, and engineered culture system innovation. The sources, isolation, and induction methods of seed cells are described, and the advantages and disadvantages of existing clinical treatment methods are compared. Furthermore, we compare existing clinical therapies and summarize promising seed cell pretreatment strategies for the first time. Several innovative engineered cell culture systems are exhibited as well. We demonstrated how to preserve cell viability through bioscaffold stiffness modulation, topographic design, and application of innovative fabrication techniques. Finally, we propose a personalized and precise regeneration strategy based on high-resolution images, digital modeling, bioprinting, and machine learning.

1 February 2025 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
TCTaoyu Chen
Taoyu Chen
GTGuoguo Tang
Guoguo Tang
TLTianhao Li
Tianhao Li
ZYZhining Yanghong
Zhining Yanghong
CHChao Hou
Chao Hou
TLTingting Li
Tingting Li
Biomacromolecules form membraneless organelles through liquid–liquid phase separation in order to regulate the efficiency of particular biochemical reactions. Dysregulation of phase separation might result in pathological condensation or sequestration of biomolecules, leading to diseases. Thus, phase separation and phase separating factors may serve as drug targets for disease treatment. Nevertheless, such associations have not yet been integrated into phase separation-related databases. Therefore, based on MloDisDB, a database for membraneless organelle factor–disease associations previously developed by our lab, we constructed PhaSeDis, the phase separation–disease association database. We increased the number of phase separation entries from 52 to 185, and supplemented the evidence provided by the original articles verifying the phase separation nature of the factors. Moreover, we included the information of interacting small molecules with low-throughput or high-throughput evidence that might serve as potential drugs for phase separation entries. PhaSeDis strives to offer comprehensive descriptions of each entry, elucidating how phase separating factors induce pathological conditions via phase separation and the mechanisms by which small molecules intervene. We believe that PhaSeDis would be very important in the application of phase separation regulation in treating related diseases. PhaSeDis is available at http://mlodis.phasep.pro.

3 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
TCTaoyu Chen
Taoyu Chen
GTGuoguo Tang
Guoguo Tang
TLTianhao Li
Tianhao Li
ZYZhining Yanghong
Zhining Yanghong
CHChao Hou
Chao Hou
TLTingting Li
Tingting Li
Biomacromolecules form membraneless organelles through liquid–liquid phase separation in order to regulate the efficiency of particular biochemical reactions. Dysregulation of phase separation might result in pathological condensation or sequestration of biomolecules, leading to diseases. Thus, phase separation and phase separating factors may serve as drug targets for disease treatment. Nevertheless, such associations have not yet been integrated into phase separation related databases. Therefore, based on MloDisDB, a database for membraneless organelle factor–disease association previously developed by our lab, we constructed PhaSeDis, the phase separation–disease association database. We increased the number of phase separation entries from 52 to 185, and supplemented the evidence provided by the original article verifying the phase separation nature of the factors. Moreover, we included the information of interacting small molecules with low or high-throughput evidence that might serve as potential drugs for phase separation entries. PhaSeDis strives to offer comprehensive descriptions of each entry, elucidating how phase separating factors induce pathological conditions via phase separation and the mechanisms by which small molecules intervene. We believe that PhaSeDis would be very important in the application of phase separation regulation in treating related diseases. PhaSeDis is available at http://mlodis.phasep.pro .